BioSpace News Archive

Data-Driven Dashboard Provides Health Plans, Employers, and Government Agencies with Expanded Insight into COVID-19 Incidence and Relative Risk within Definable Populations

Science 37, the industry leader in virtual clinical trials, announced today that Mike Zaranek has joined the company as its chief financial officer (CFO). He will oversee all aspects of finance, accounting, and

Samsung Biologics announced it has attained ISO22301 certification for additional business operations, demonstrating its unsurpassed commitment to ensuring client satisfaction and operational excellence through its world-class business continuity management system.

Highly experienced physician with an excellent track record in clinical development at early stage biotech and big pharma

Gossamer Bio, Inc. announced the pricing of its underwritten public offering of 9,433,963 shares of its common stock at a price to the public of $13.25 per share and the pricing of $200.0 million aggregate principal amount of its 5.00% convertible senior notes due 2027.

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives, announces that its Phase II clinical study has met its endpoints of safety, efficacy, and dose selection.

New Jersey’s only NCI-designated Comprehensive Cancer Center becomes the 37th member of Caris’ collaborative network focused on expanding the application of precision medicine in cancer treatment

Presentation Will Include Preclinical Data of IMU-838 Against SARS-CoV-2 as Well as First Pharmacokinetic Data From the Ongoing Phase 1 Clinical Trial of IMU-935

QPS, a global contract research organization that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics.

Microbix Biosystems Inc., an award-winning life sciences innovator and exporter, announces that it has achieved full utilization of the six bioreactor units it installed for manufacturing the “antigens” which are at the core of immunoassays that establish exposure or immunity to the Rubella virus, the cause of German Measles.